💡 We don’t necessarily need more drugs for #RA - we need to use existing ones more effectively. Here's a recent article of the @ec.europa.eu's HORIZON magazine on SQUEEZE, feat. @danielaletaha.bsky.social & @agneskocher2.bsky.social
projects.research-and-innovation.ec.europa.eu/en/horizon-m...
High disease activity is high disease activity is high disease activity?
- Nope!
Not all patients with rheumatoid arthritis are the same – even when they have exactly the same disease activity score!
Full article: pubmed.ncbi.nlm.nih.gov/41839530/
Part of #SPIDERR and @squeezeproject.bsky.social
Congratulations to our scientific coordinator @meduniwien.ac.at for 30 years of University Rheumatology in Austria! Learn more about SQUEEZE via: squeeze-project.eu
New publication on therapeutic drug monitoring of biological drugs. Certolizumab plasma concentrations were influenced by dose & dose adjustments in a predictable manner shows newly published data by REMEDY and SQUEEZE: journals.lww.com/drug-monitor...
SQUEEZE tries to understand why #RheumatoidArthritis (RA) behaves so differently from one person to another & how this knowledge can help make treatment more personalised. This paper led by LUMC shows that WHERE #RA affects the body at diagnosis really matters: www.nature.com/articles/s41...
💊 Taking medication sounds simple - but for many people with RA, it isn’t. A scoping review protocol led by @agneskocher2.bsky.social et al. in 2024 focused on #adherence to DMARDs. This work reviews decades of research to better understand what influences adherence: osf.io/gb8dk/files/...
Learn more about the SQUEEZE project by exploring one of our first publications. 📰 rmdopen.bmj.com/content/10/4...
The #SQUEEZE care model is being presented at Oslo @squeezeproject.bsky.social meeting
We will finally get to know the 3 components 😍: ePROM assessment-> segmentation-> tailored adherence intervention
When @squeezeproject.bsky.social people meet during the summer 🌞🕶️
At the Dresden Symposium on Autoantibodies 2025, Daniela Sieghart presented on biomarkers for RA treatment response, highlighting EU projects @squeezeproject.bsky.social
& @autopix.bsky.social. Our division drives precision medicine forward, tailoring care through innovative biomarkers.
How to run #clinicaltrials in EU consortia? SQUEEZE expert Daniela Sieghart of @meduniwien.ac.at shares insights into the work of managing clinical studies during the Austrian Research Promotion Agency Coffee Chats on "Health in Action". 🎬 Watch the full talk via www.youtube.com/watch?v=3u6U...
Where's your SQUEEZE bag spending the summer? 😉☀️
How can we possibly fill the void after the end of #EULAR2025? Maybe by watching @eular.org's Kristina Chingov explain how to involve patient research partners in EU consortia during an Austrian Research Promotion Agency #FFG -led virtual coffee talk. ☕ Watch via 👉 www.youtube.com/watch?v=oyOC...
#EULAR2025 also offered the possibilty to come together for scientific project meetings.
The @squeezeproject.bsky.social
Wp8 team spent very productive 2 hours on steering the trajectories for our #adherence and #implementation ideas
Check out my interview, masterfully led by Valentina Pucino after the plenary session of #EULAR2025 👇
www.youtube.com/watch?v=d6hi...
Full house and engaging discussions at Tjardo Marseveens (LUMC) talks today at #EULAR2025! Follow the SQUEEZE project on our LinkedIn channel or website to learn more about our latest results:
LinkedIn: www.linkedin.com/company/sque...
Web: squeeze-project.eu
We're back for Day 3 of #EULAR2025 with insights on the latest science done by the SQUEEZE consortium. Join us at booth #O3 in the glass walkway, near the Science Café. Our SciComm team is ready to introduce you to the work done in our project!🤗 @nicoleschmidtvie.bsky.social @caro-neum.bsky.social
Evaluation of the Torque Teno Virus as a potential immunologic marker in #RheumatoidArthritis presented by Daniel Mrak today. Interested in the potential of TTV as an "immunometer"? Follow @ttvguidetx.bsky.social on TTV-guided dosing of immunosuppressive drugs in kidney transplant recipients. #TTV
If you are at #EULAR2025, come and visit us at our stand in the Glass Walkway in the NPO Exhibition. You can win an anti-stress hippo and learn more about our HIPPOCRATES project including our HPOS study.
👉 hippocrates-imi.eu
👉 www.hpos.study
We had the great pleasure of welcoming a special guest at our booth yesterday. We consider ourselves very fortunate to have @danielaletaha.bsky.social & his glorious team at @meduniwien.ac.at leading our project. EU projects are highly complex & it's crucial to cruise with the right captain & crew!
At 3.15 pm today, SQUEEZE expert Daniela Di Giuseppe will present a poster during the poster tour comparing biological, targeted & conventional options of second DMARDs after #MTX in European RA cohorts. We are trying to understand which second #DMARD choice is the best for which group of patients.
Want to learn more about the contextual analysis done to develop the SQUEEZE Care Model? Come join us at booth #O3 in the NPO area / glass walkway and study the poster presented yesterday by the @inmusc.bsky.social team around @loreto-carmona.bsky.social. #EULAR2025
Full house and engaging discussions during @nilssteinz.bsky.social ‘s talk “Add-on vs. Replacement csDMARD Strategies Post-Methotrexate: A European analysis on csDMARD Treatment Choices" - exciting research funded by @squeezeproject.bsky.social & sister project SPIDERR led by Rachel Knevel at LUMC.
Day 2 of #EULAR2025 kicking off with a first highlight. Here's SQUEEZE expert @nilssteinz.bsky.social (LUMC) getting ready at the SQUEEZE booth for his talk "Add-on vs. Replacement csDMARD Strategies Post-Methotrexate: A European analysis on csDMARD Treatment Choices". 📍 Starting NOW in room A.2!
@meduniwien.ac.at is everywhere! 🤙🏼🥰
Day 1 at #EULAR2025 is coming to an end and we were happy and proud about the strong poster presence we had today by SQUEEZE experts from @inmusc.bsky.social and @meduniwien.ac.at i.e. on challenges in implementing evidence-based health interventions in the European Union.
Join by at the poster presentation of Claudia Hana on trajectories of #MTX use in patients with RA this afternoon at m348
@squeezeproject.bsky.social
#EULAR2025
Meet #RheumaBuddy Andreas Dam, our SQUEEZE superhero on a quest to improve the lives of #RA patients. At SQUEEZE we are working on squeezing the most out of existing DMARDs through three clinical trials led by Queen Mary Universit London, @meduniwien.ac.at and Diakonhjemmet Hospital Oslo. #EULAR2025
Two people in front of the SQUEEZE congress booth
Our booth is ready! And we are too! The #SQUEEZE booth team @nicoleschmidtvie.bsky.social and @caro-neum.bsky.social is geared up for #EULAR2025. Join us for chats about our three clinical trials, the SQUEEZE Care Model, the HealthBuddy App and #patientengagement.📍 Booth #O3 👥 #Rheumatology #RA